re: MIZZOU is curing cancer

quote:

---

the808bass

---

So you have no facts, just assumptions?? Got ya.

To approve any drug the FDA requires drug companies show there drug is more effective than a placebo in 2 clinical trials, and the negative results are discarded.

Since you are to lazy to look it up i will give you an easy place to hear it.

8:40 mark

God why are all you Mizzou fans so dumb and uneducated?

Why do Mizzou fans think assumptions will stand in an argument instead of bringing facts?

quote:

---

I'm not assuming anything. It costs ~$1B to bring a new drug to market.

Drugs are subject to ongoing review. Even if a drug beats placebo (by a statistically significant margin), it may not be approved on the basis of side-effects.

After approval, the drug is subject to post-approval monitoring. Side effects which are reported can be the basis for re-labeling, a change in indication or even a black box warning (the basic death knell of a drug).

Your simplistic naïveté serves no purpose.

---

No crap, do you know how to read? I was discussing Clinical trials.

quote:

---

quote:
People need to do research about Clinical trials


Yea its crazy what it costs, and that a drug only has to have positive results twice to get approved. Pharma industry is one f'd up place these days.

---

So you admit that the following statement was sloppy, incorrect and generally misleading?

quote:

---

and that a drug only has to have positive results twice to get approved

---

quote:

---

So you admit that the following statement was sloppy, incorrect and generally misleading?

---

What that for a drug to be approved through clinical trials it only has to out perform the placebo 2 times? No i do not. Nor will i ever. I can't help it that you can't figure out what i was saying.

This is cool, but boron neutron capture is not a new idea and it was not developed at Mizzou. This isn't meant to denigrate the work done at Mizzou, just to point out that it's not exactly earth-shattering. If I had a nickle for every rosy article published by the public relations divisions at research institutions...

Relying purely on the enhanced permeability and retention effect of tumors (which this researcher seems to be doing) for selective uptake of boron is not going to be enough. I was in a research group during college where we were working on liposome delivery systems for chemotherapy agents so I'm well aware of this problem.

As someone who works in radiation oncology, I'm glad to see so many people working on new methods for using radiation to treat cancer. I especially look forward to the use of heavy ion therapy and neutron capture techniques.